TOPICREM reaches a new milestone in its scientific commitment with the publication of its first study in the Journal of Cosmetic Dermatology (JCD), a leading international journal in dermo-cosmetics.

This publication highlights the results of a clinical study conducted on two flagship products: the Relipidizing Cleansing Oil and the DA PROTECT Emollient Balm, developed to meet the specific needs of atopic-prone skin.

Clinically proven results

The study underscores the benefits of daily use of these products, including:

· strengthening of the skin barrier
· improvement in hydration and comfort
· a significant contribution to quality of life and emotional well-being in patients with atopic dermatitis

These results confirm TOPICREM’s expertise in developing skincare that combines dermatological performance with sensorial appeal.

A commitment to patients

This publication reflects TOPICREM’s determination to rely on robust scientific data to support patients in their daily lives. It also demonstrates the teams’ dedication to designing innovative formulas aimed at sustainably improving the comfort of sensitive and atopic skin.

👉 View the full study: HERE